Tag: Drug

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly Decreasing the burden of TB in Romania through reforming the TB control system and strengthening the management of drug resistant forms of

    Neftaly Decreasing the burden of TB in Romania through reforming the TB control system and strengthening the management of drug resistant forms of

    Neftaly: Decreasing the Burden of TB in Romania Through Reforming the TB Control System and Strengthening the Management of Drug-Resistant Forms

    Tuberculosis (TB) remains a critical public health challenge in Romania, which bears one of the highest TB burdens in the European Union. Despite progress in recent years, the emergence of drug-resistant TB (DR-TB) and systemic inefficiencies continue to threaten national TB control efforts. Neftaly is committed to supporting Romania in its fight against TB by contributing to the reform of its TB control system and enhancing the management of drug-resistant forms of the disease.

    Addressing the Core Challenges

    The current TB control system in Romania faces several key issues:

    • Fragmented service delivery between primary care, public health institutions, and hospitals
    • Insufficient diagnostic capacity, particularly for rapid drug resistance testing
    • Gaps in patient-centered care, leading to poor treatment adherence
    • Limited integration of social support and mental health services for TB patients

    These challenges are compounded in the management of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, which require longer, more complex, and more expensive treatment regimens.

    Neftaly’s Strategic Response

    Neftaly’s strategy focuses on systemic reform and targeted capacity-building through the following pillars:

    1. Modernizing TB Surveillance and Diagnostics

    We support the scale-up of rapid molecular diagnostics (such as GeneXpert and line probe assays) to ensure timely and accurate detection of drug resistance. Enhanced electronic reporting systems will also enable real-time tracking and response.

    2. Improving Access to Quality Treatment

    Neftaly works with national partners to ensure that patients with TB and DR-TB receive WHO-recommended, shorter, and more effective treatment regimens. This includes improving drug supply chains, reducing treatment delays, and decentralizing care delivery.

    3. Strengthening Human Resources and Clinical Management

    Training healthcare providers on the latest TB and DR-TB management guidelines is key. Neftaly facilitates workshops and mentoring for clinicians, nurses, and community health workers across Romania, improving quality of care and case management.

    4. Promoting Patient-Centered, Community-Based Care

    Neftaly advocates for a shift from hospital-based to ambulatory, community-driven TB care. By involving civil society and patient organizations, we promote adherence, reduce stigma, and improve treatment outcomes.

    5. Policy Advocacy and System Reform

    Neftaly engages with government stakeholders to align Romania’s TB response with international best practices. This includes revising national protocols, securing sustainable financing, and integrating TB control within broader health system reforms.

    Results We Aim For

    Through this comprehensive approach, Neftaly aims to:

    • Reduce TB incidence and mortality in Romania
    • Improve detection and treatment success rates of DR-TB
    • Strengthen national capacity for disease surveillance, treatment, and prevention
    • Promote equity in access to TB services, especially for vulnerable and marginalized populations
  • Neftaly Generating and utilising strategic informationn on drug use related interventions in the region

    Neftaly Generating and utilising strategic informationn on drug use related interventions in the region

    Neftaly: Generating and Utilising Strategic Information on Drug Use–Related Interventions in the Region

    Overview

    Neftaly is committed to strengthening the regional response to drug use by enhancing the generation, analysis, and utilization of strategic information. Effective drug use–related interventions must be grounded in accurate, timely, and context-specific data. Through a multi-sectoral and rights-based approach, Neftaly supports evidence-driven policies and programs that address the health, social, and structural dimensions of drug use in the region.


    Objective

    To improve the effectiveness of drug use–related interventions by building regional capacity to generate high-quality strategic information and apply it for policy-making, program design, implementation, and monitoring in participating countries.


    Key Areas of Focus

    1. Strengthening Data Collection Systems

    • Support the development and integration of drug use surveillance systems into national health and law enforcement data platforms.
    • Promote standardized data collection methodologies for consistency across countries.
    • Work with community-based organizations to gather qualitative and quantitative data from people who use drugs (PWUD), including those in hidden and high-risk settings.

    2. Enhancing Data Quality and Analysis

    • Provide technical assistance for data validation, management, and disaggregation by age, gender, and risk behavior.
    • Encourage triangulation of data from health, criminal justice, and social sectors to produce comprehensive situational assessments.
    • Build regional analytical capacity to interpret trends in drug use patterns, harm reduction needs, and service gaps.

    3. Supporting Evidence-Based Program Planning

    • Use strategic information to inform the design and scaling of harm reduction services such as needle and syringe programs (NSPs), opioid substitution therapy (OST), and overdose prevention.
    • Identify priority areas and high-risk populations for targeted interventions.
    • Promote the use of modeling tools to project future needs and evaluate the impact of policy changes.

    4. Facilitating Knowledge Sharing and Regional Coordination

    • Establish regional knowledge hubs and learning exchanges to share good practices and research findings.
    • Engage governments, civil society, academia, and international partners in collaborative dialogue and peer learning.
    • Encourage the development of regional guidelines and frameworks for data use in drug policy and program development.

    5. Empowering Communities and Stakeholders

    • Involve people who use drugs in data collection, program evaluation, and research initiatives to ensure meaningful participation.
    • Provide training for civil society organizations on how to interpret and use data for advocacy and service delivery.
    • Strengthen accountability by promoting transparency in how data informs funding and policy decisions.

    Outcomes and Impact

    • Improved availability and reliability of strategic information to guide drug use interventions.
    • Stronger regional coordination in responding to emerging trends and cross-border challenges related to drug use.
    • Increased investment in harm reduction and public health approaches, guided by evidence and best practices.
    • Enhanced capacity of stakeholders to monitor progress, identify service gaps, and promote the rights and health of people who use drugs.

    Conclusion

    Neftaly’s focus on strategic information is central to building smarter, more responsive drug policies in the region. By bridging data with action, Neftaly empowers governments, communities, and civil society to create safer, healthier environments for all — especially those most vulnerable to the harms of drug use.

  • Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly Tuberculosis (TB) Treatment Success Enhancement Initiative

    Goal:
    To increase the TB treatment success rate among drug-susceptible patients from 85% in 2017 to 90% by 2020.

    Project Overview:
    The Neftaly TB initiative aimed to strengthen treatment adherence and quality of care for patients with drug-susceptible tuberculosis (DS-TB). Focused on improving treatment outcomes, the project implemented patient-centered support systems, strengthened health service delivery, and enhanced monitoring mechanisms to reduce loss to follow-up and treatment failure.

    Objectives:

    • To improve adherence to TB treatment regimens through community-based support and follow-up.
    • To reduce default rates by addressing barriers such as stigma, misinformation, and lack of access to care.
    • To train healthcare providers on patient management, counseling, and side-effect monitoring.
    • To implement real-time tracking and reporting systems to ensure continuous patient engagement and support.
    • To strengthen the Directly Observed Treatment, Short-course (DOTS) strategy through better supervision and community involvement.

    Key Interventions:

    • Deployment of community health workers and peer supporters to provide regular follow-ups and counseling.
    • Integration of nutritional and psychosocial support for vulnerable TB patients.
    • Use of digital adherence technologies (e.g., SMS reminders, phone-based follow-up) to reinforce treatment compliance.
    • Strengthening of TB recording and reporting tools to track patient outcomes accurately.
    • Coordination with national TB programs and local partners to align with broader public health goals.

    Impact:

    • Improved treatment adherence and reduced loss to follow-up.
    • Increased patient satisfaction and trust in the health system.
    • Enhanced capacity of healthcare providers to deliver patient-centered TB care.
    • Achievement of a treatment success rate approaching or exceeding the 90% target by 2020.
    • Contribution to national and global TB elimination strategies through sustainable, scalable practices.